Subconjunctival Myolipoma Confirmed with Immunohistochemical Analysis: A Case Report by Asadi-Amoli, Fahimeh et al.
This work is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Journal of Ophthalmic and Optometric Sciences. Volume 3, Number 2, Spring 2019, In Press
Case Report
Subconjunctival Myolipoma Confirmed 
with Immunohistochemical Analysis: A Case 
Report
Fahimeh Asadi-Amoli 1 , MD; Mohammad Soleimani *2, MD;  Zohreh 
Nozarian 1, MD;  Reza Garebaghi 3, MD;  Tooba Ghazanfari 4, MD;  Maryam 
Parvizi 4, MD;  Keivan Rezaei 2, MD;  Seyed Ali Tabatabaei 2, MD
1. Department of Pathology, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, 
Iran.
2. Department of Ophthalmology, Eye Research Center, Farabi Eye Hospital, Tehran University 
of Medical Sciences, Tehran 1336616351, Iran.
3. International Virtual Ophthalmic Research Center, Tehran, Iran.
4. Immunoregulation Research Center, Shahed University, Tehran, Iran.
5. Department of Pathology, Shahid Labbafinejad Medical Center, Shahid Beheshti University 
of Medical Sciences, Tehran, Iran.
*Corresponding Author: Mohammad Soleimani
E-mail: Soleimani_md@yahoo.com
How to cite this article: Asadi-Amoli F, Soleimani M, Nozarian Z, Garebaghi R, Ghazanfari T, Parvizi M, 
Rezaei K, Tabatabaei SA. Subconjunctival Myolipoma Confirmed with Immunohistochemical Analysis: A 
Case Report. Journal of Ophthalmic and Optometric Sciences . 2019;3(2):
Article Notes:
Received: Aug. 12, 2018
Received in revised form: Sep.
29, 2018
Accepted: Nov. 10, 2018







Purpose: To report the clinicopathological features of a rare case 
of subconjunctival myolipoma and its treatment results.
Case Report:  A 17-year-old female patient referred to our center 
with a white-pink mass in her left upper bulbar conjunctiva. The 
lesion extended to the forniceal conjunctiva. The patient had 
otherwise normal complete ocular examinations and underwent 
complete surgical excision of the mass due to cosmetic 
concerns. The tumor was examined with light–microscopy, 
following hematoxylin and eosin (H&E), Masson-trichrome, and 
immunohistochemical (IHC) staining. 
A definite diagnosis of subconjunctival myolipoma was acheived 
following the pathological assessment. Six months postoperatively, 
no tumor recurrence was noted, and ocular examinations were 
within normal limits. 
Conclusion: To date, only a few cases of orbital myolipoma have 
been reported in the literature. To the best of our knowledge, the 
current manuscript is the first report of subconjunctival myolipoma 
in the English literature. A straightforward diagnosis is possible 
through pathological assessment of the excised tumor and surgical 
treatment shows good results.
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this mass six months prior to the visit, which 
was asymptomatic, and due to cosmetic 
concerns, had decided to excise the lesion. 
This subconjunctival mass was not mobile 
and was covered with intact white-pink color 
conjunctiva with no associated features 
including hair follicle, tenderness or sentinel 
vessels. 
Patient’s corrected distance visual acuity 
(CDVA) using Snellen visual acuity chart 
was 20/20 in both eyes and refraction was 
within normal limits. Intraocular pressure 
was 15 mmHg in both eyes and extraocular 
movements were also normal. The posterior 
and anterior segment examinations were 
unremarkable. A systematic review of the 
patient’s history and physical examination 
was normal.
Following a written informed consent 
from the patient’s father, surgical excision 
was performed using non-touch technique 
with 2 mm uninvolved margin under 
topical anesthesia with 0.05 % tetracaine 
(Anestocaine, Sina Darou, Tehran, Iran) and 
2.5 % phenylephrine (Sina Darou, Tehran, 
Iran). The lesion was localized and totally 
excised then stored in a sealed container 
consisting of 10 % formalin and sent for routine 
pathology examination. Postoperatively eye 
drop of  0.5 % chloramphenicol (Sina-Darou, 
Introduction
Myolipoma of the soft tissue, which was first 
described in 1991 is commonly reported in 
the abdominal cavity and retroperitoneum1, 2 
and is defined as a benign tumor consisting of 
mature adipose cells mixed with differentiated 
smooth muscle cells 3. This is an exceedingly 
rare tumor with less than 50 reported cases in 
the literature and female preponderance 4. In 
1998, the first case of orbital myolipoma was 
reported in a 67-year-old female as left lower 
medial eyelid involvement and in 2003 the 
second case was reported, who was a 41-year-
old Japanese female with right extraconal 
mass. In both patients, the diagnosis of 
myolipoma was confirmed using histological 
examination, immunohistochemical (IHC) 
staining, and transmission electron microscopy 
assessment  5, 6.
To the best of our knowledge, the present 
manuscript presents the first rep[ort of 
subconjunctival myolipoma in English 
literature. 
Case report
A 17-year-old immunocompetent female 
presented with a mass of white-pink color in 
the left upper bulbar conjunctiva, extended 
and limited to the forniceal conjunctiva 
(Figures 1A and 1B). The patient had noted 
Figure 1: Slit photographs showing the clinical appearance of the white-pink color mass 
in the left upper bulbar conjunctiva (A), extended toward the forniceal conjunctiva (B)
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Tehran, Iran) every six hours and 0.1 % 
fluorometholone (Fluocort 0.1 %, Sina-Darou, 
Tehran, Iran) every eight hours was prescribed 
for one month for her left eye.
The macroscopic examination revealed two 
soft fragments of creamy-gray tissue, covered 
by mucosa measuring 8 mm × 7 mm in surface 
and 4 mm in thickness. The specimen was 
wrapped in a filter paper and totally submitted 
for histopathological processing.
The paraffin sections were stained using 
hematoxylin and eosin (H&E) staining, and 
following the inspection of the pathological 
features of a tumor, it was decided to use 
further stains, including Masson-trichrome 
and immunohistochemical (IHC) staining. We 
used the following antibodies for IHC staining: 
HMB45 (Biogenex, San Ramon, CA; Ready-
to-Use Antibody), actin (Biogenex, San 
Ramon, CA; Ready-to-Use Antibody), desmin 
(Biogenex, San Ramon, CA; Ready-to-Use 
Antibody), estrogen receptor (ER) (Biogenex, 
San Ramon, CA; Ready-to-Use Antibody), 
S100 protein (Biocare Medical, Walnut Creek, 
CA; Ready-to-Use Antibody) as well as 
smooth muscle actin (SMA) (Biocare Medical, 
Walnut Creek, CA; Ready-to-Use Antibody).
Light-microscopic examination of the H&E 
stained tissue showed mature adipose cells 
with no lipoblasts or floret-like giant cells, 
intermingled with spindle-shaped cells 
revealing a sieve-like pattern covered with 
conjunctival epithelium, which was not 
associated with atypical features, including 
apoptotic bodies, mitotic figures or necrosis 
(Figures 2A, 2B and 2C). Also, Masson-
trichrome staining revealed muscle fibers in 
red color and collagen fibers in blue color 
(Figure 2D).  The IHC staining revealed a 
positive reaction as brown staining with actin 
(Figure 3A), desmin (Figure 3B), and SMA 
(Figure 3) in muscle fibers and S100 protein 
(Figure 3) in mature adipocytes, yet the tumor 
was immunonegative for HMB45 (Figure 3) 
or ER (Figure 3). Considering the above-
mentioned pathological findings, the definite 
pathological diagnosis of subconjunctival 
myolipoma was reached.   
The examination of the patient, six months 
after the operation showed no signs of mass 
recurrence.
Discussion
Smooth muscle actin (SMA) expression by 
myofibroblasts is used for identification of 
these cells 7-9 and the presence of desmin has 
been observed in most smooth muscle cells 
and striated muscle cells 10. In the current case, 
the smooth muscle component of the tumor 
was immunopositive for actin, desmin, and 
SMA, which was compatible with its muscle 
Figure 2: Subconjunctival myolipoma 
H&E staining: (A), (B) and (C) sections 
show subepithelial mature adipose tissue 
mixed with differentiated muscle fibers 
with band oval nuclei (H&E; original 
magnification ×40, ×100 and ×400, in A, 
B and C sections respectively). Masson-
trichrome staining demonstrates muscle 
fibers in red color and collagen fibers in 
blue color (Masson-trichrome; original 
magnification ×400) (D)
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element. This immunoreactivity was similar 
to Fukushima’s myolipoma case series, who 
observed desmin immunoreactivity in 100 % 
and SMA immunoreactivity in 95 % of their 
cases 4. Also, immunoreactivity for SMA and 
desmin in the first 5 and for SMA in the second  6 
reported case of the orbital myolipoma 
was similar to our findings. Furthermore, 
studies have shown that mature lipocytes are 
immunoreactive for S 100 protein11 12, which 
was observed in the lipid component of the 
tumor in the present case and confirmed the 
second component of the subconjunctival 
myolipoma.  
Myoplipoma is an extremely rare tumor, and 
its presentation in ocular structures was first 
described in 1998 by Sharara et al.,5 in a 67-year-
old female with left lower lid mass, whose 
diagnosis was confirmed using H&E, Masson 
trichrome, IHC staining, and  conventional 
transmission electron microscopic assessment. 
A strong positive reaction was noted for 
desmin and SMA in smooth muscle fibers and 
for Masson trichrome in non-striated intra-
cytoplasmic filaments, which are comparable 
with findings of the present case report 5. We 
did not perform a conventional transmission 
electron microscopy assessment due to the 
inaccessibility of the equipment in our center. 
The second case of orbital myolipoma, which 
was presented as exophthalmos of the right 
eye, in a 41-year-old Japanese female, was 
described by Nagayama et al., 6 in 2003. 
This orbital myolipoma was located in the 
extraconal space of the right orbit, measuring 
30 millimeters × 20 millimeters, as revealed 
in axial Tl-weighted magnetic resonance 
imaging. The excised tumor was examined 
pathologically using H&E, Masson trichrome, 
and IHC staining, together with conventional 
transmission electron microscopy assessment 6. 
In IHC staining, a strong positive reaction was 
noted for SMA, yet none for Melan A, HMB45, 
and estrogen receptors 6. The findings of the 
present investigation were in agreement with 
their case report. Despite a positive reaction 
with estrogen receptor, which was reported 
in 13 out of 15 myolipoma cases of the non-
ocular site by Fukushima et al. , 4 we found 
no positive reaction with the estrogen receptor 
our case similar to the patient reported by 
Nagayama et al., 6 .  This difference could be 
attributed to the difference in the location of 
the tumor in the orbital structures.
Similar to our case the majority of reported 
Figure 3: Subconjunctival myolipoma 
IHC staining: positive reaction as brown 
staining with actin (IHC; original 
magnification ×100) (A), desmin in muscle 
fibers (IHC; original magnification ×100) 
(B), SMA (IHC; original magnification × 
400) (C), and brown staining with S100 
in mature adipocytes (IHC; original 
magnification ×400) (D). Negative reaction 
is seen in staining with HMB45 (IHC; 
original magnification ×100) (E) and ER 
(IHC; original magnification ×100) (F)
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myolipoma cases in the literature are females. 
In the case-series published by Fukushima 
et al.,4 94 % of subjects were female while 
both cases of orbital myolipoma previously 
reported  were females 5 6. However, a clear 
rationalization for this gender preponderance 
is yet to be determined. 
Conclusion
To date, only a few cases of orbital myolipoma 
have been reported in the literature. To the best 
of our knowledge, the current manuscript is 
the first report of subconjunctival myolipoma 
in the English literature. A straightforward 
diagnosis is possible through pathological 
assessment of the excised tumor and surgical 
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